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Abstract
Background: Up to now it has not been systematically investigated in which kind of clinical
situations a consultation style based on shared decision making (SDM) is preferred by patients and
physicians. We suggest the factorial survey design to address this problem.
This method, which so far has hardly been used in health service research, allows to vary relevant
factors describing clinical situations as variables systematically in an experimental random design
and to investigate their importance in large samples.
Methods/Design: To identify situational factors for the survey we first performed a literature
search which was followed by a qualitative interview study with patients, physicians and health care
experts. As a result, 7 factors (e.g. "Reason for consultation" and "Number of therapeutic options")
with 2 to 3 levels (e.g. "One therapeutic option" and "More than one therapeutic option") will be
included in the study. For the survey the factor levels will be randomly combined to short stories
describing different treatment situations.
A randomized sample of all possible short stories will be given to at least 300 subjects (100 GPs,
100 patients and 100 members of self-help groups) who will be asked to rate how the decision
should be made. Main outcome measure is the preference for participation in the decision making
process in the given clinical situation.
Data analysis will estimate the effects of the factors on the rating and also examine differences
between groups.
Discussion:  The results will reveal the effects of situational variations on participation
preferences. Thus, our findings will contribute to the understanding of normative values in the
medical decision making process and will improve future implementation of SDM and decision aids.
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Background
Shared decision making
Currently we are witnessing a change in the traditional
physician-patient-relationship. Shared decision making
(SDM) has become increasingly popular in the last decade
[1]. Many patients no longer rely only on their physician's
opinion about the best treatment. They have gained self-
confidence and many of them want to participate in deci-
sions or even be the only responsible decision maker [2-
4].
Charles et al. [5] point out four conditions that must be
met to classify the physician-patient interaction as shared
decision making:
- there are at least two involved: the physician and the
patient
- both are incorporated into the process of treatment deci-
sion making
- sharing information is the basic condition of SDM
- both agree with the decision made
Research on SDM
Reviews demonstrate multiple favorable effects of SDM
and related decision aids. SDM seems to increase patients'
satisfaction, quality of life, treatment compliance, knowl-
edge about the disease and the therapeutic options, per-
ceived control of the disease and symptom control [6-9].
However, a recent review suggests that SDM might be use-
ful only under certain circumstances, i.e. related to
chronic illness and mental health problems [1].
Other studies analysed the effects of certain patient char-
acteristics on his/her preferences either to participate or
not to participate in the medical decision making process.
In regard to socio-demographic variables, research mainly
focused on age, educational level and gender. Most of the
studies demonstrate a tendency for women [3,10],
younger [11-13] and more highly educated people
[4,14,15] to prefer more participation. Even so, there are
studies which showed opposing results for gender [14]
and a lack of association with educational level [16].
Increasingly, health professionals agree that all patients
should be offered SDM irrespective of age, gender or for-
mal education.
When should SDM be used?
Whereas there have been many studies on patients' char-
acteristics and participation preferences, the role of the
treatment situation has hardly been investigated. There
might be a difference whether there are severe side effects
to a treatment or not, whether there are various options or
only one, whether the condition to be treated is life threat-
ening or not, on the degree to what extend SDM is
regarded as appropriate or not. Up to now, most studies
dealing with situational factors related to SDM prefer-
ences only focused on one dimension of the treatment sit-
uation. Furthermore, there are only a few studies
addressing the normative question when SDM should be
applied. Mc Kinstrey [16] confronted patients with video
vignettes of consultations about five different themes
(serious acute, minor acute, chronic, mental health and
lifestyle), using either a shared decision or a directive con-
sultation style. In this study, patients were more likely to
prefer SDM in situations dealing with psychological prob-
lems or lifestyle. Similarly, Deber et al. [17] showed, in
another vignette study, that in situations involving a
potential life threatening disease there was a greater pref-
erence for giving control to the physician than in situa-
tions involving a minor disease or quality of life. If more
than one treatment alternative exists, patients generally
want to be involved in treatment decisions according to
Guadagnoli and Ward [18].
What has been less considered is that real treatment situa-
tions are characterized by several dimensions and the
complex interactions of these dimensions. Against this
background, Whitney [19] developed a model addressing
the normative question when SDM should be used. He
characterized treatment situations by the level of impor-
tance of the medical decision for the patient and by the
level of the physician's certainty about the efficacy of the
therapeutic options. According to this model, decisions
that are of high importance for the patient in combination
with a low physician's certainty should be made by the
patient, whereas the physician should make decisions of
high treatment certainty with low importance for the
patient. The remaining decisions should be shared.
However, this model does not include dimensions named
before like the number of therapeutic options and side
effects of therapeutic options. Up to know it is still not
clear, which dimensions of treatment situations are
important in answering the question when SDM is pre-
ferred. As a first step we suggest a factorial survey of
patients and physicians.
Analysing values in complex decisions: the role of the 
factorial survey
The method of the factorial survey was developed by Rossi
and Anderson [20] in the eighties to study opinions, atti-
tudes and decisions related to complex situations. It com-
bines the strength of a classical experiment with the
advantage of a sample survey design. Like an experimental
design, it allows to manipulate several variables. At the
same time a large number of subjects can participate with-
out undue expense [21].BMC Health Services Research 2008, 8:260 http://www.biomedcentral.com/1472-6963/8/260
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In a factorial survey, realistic vignettes, i.e. short narratives
of situations or actors, are presented to the subjects. It dif-
fers from other vignette surveys in that the characteristics
(factors) are varied in a systematic way [22]. Subjects rate
the vignettes on a scale depending on the research ques-
tion, e.g. indicating what kind of decision one should
make in that specific situation. Each respondent receives a
set of stories with varying combination of characteristics.
The aim of the statistical analysis is to explore the impor-
tance of each factor and interactions between different fac-
tors. Furthermore, differences in rating between
respondents or groups of respondents can be analysed
[22] including demographic variables [23].
Developed in the social sciences, factorial surveys have up
to now been applied in many different fields proving their
versatility and utility as a research method. A wide range
of topics has been covered, e.g. consumer preferences
[24], how people define alcohol abuse [25] and how cou-
ples decide to move [26].
Lauder [21] claims that factorial surveys help to under-
stand the factors that underlie clinical judgments of health
care professionals. Yet, there are only a few published
examples in health services research. Currently, factorial
surveys were occasionally undertaken in nursing science
[21,27-29]. Furthermore, the method was used to investi-
gate the reasons that make a medical error unacceptable
[30], the factors influencing the reaction to medical errors
[31] and how physicians decide to prescribe benzodi-
azepines for nervousness and insomnia [32].
Hypothesis
We consider the factorial survey to be a feasible method to
analyse the variables underlying the decision making
process in the medical encounter. It will help to reveal the
importance of different situational factors, determining
when patients and physicians prefer SDM. Furthermore, it
might serve as a tool to analyse differences between
patients and physicians in this domain.
Methods/design
Choosing factors in a systematic way
While factors for factorial surveys are often chosen some-
what haphazardly based on literature and individual
researchers' perceptions, we undertook a qualitative study
to identify systematically the input for our main survey
[23].
We developed an interview guideline based on published
literature on situational factors related to SDM. 12 physi-
cians, 15 patients and 14 experts in the health care system
were interviewed. Among the latter there was a represent-
ative of the German Federal Ministry of Education and
Research, the national Commissioner for Patients' Affairs,
a speaker of The National Association of Statutory Health
Insurance Physicians and a member of The Agency for
Quality in Medicine.
In this qualitative study we covered three key areas: char-
acteristics of the disease, characteristics of therapeutic
options and characteristics of the patient. For each topic
participants were asked to mention factors influencing the
decision making process with regard to the person who
should make the decision. In a second step, interviewees
were asked about their opinion on the importance of the
factors mentioned in the literature. The interviews were
recorded, transcribed and quantitatively and qualitatively
analysed using an inductive coding system.
In total we found 32 factors, 9 related to the disease i.e.
severity, 8 related to the therapeutic options i.e. whether
there is only one or more than one therapeutic option and
15 related to the patient i.e. the wish of the patient to par-
ticipate.
To reduce the number of factors, we combined factors
with similar contents and excluded those that were men-
tioned by only a few people. Furthermore, we excluded
most patient characteristics, because the focus of our work
is based on situational factors. As a result we finally
achieved a 7-factor solution for the survey (see table 1).
To construct vignettes, for each factor specific levels have
to be defined. Few levels are to be preferred in order to
keep the number of possible vignettes small [33]. There-
fore we did not include more than 3 levels for each factor.
In factors like "time until treatment should be started" we
introduced only two levels, i.e. "immediate treatment nec-
essary" vs. "no time pressure". Table 1 gives an overview
of all factors and their levels finally included in our study.
Creating vignettes
The principle of a factorial survey is to combine all levels
of one factor with all levels of the other factors. Therefore,
for writing a vignette, one level of a factor is randomly
combined with one level of all other factors, resulting in a
description of a specific situation.
Given 7 factors with 2 to 3 levels in our study, we get 432
possible vignettes by 3 × 2 × 2 × 2 × 3 × 3 × 2. Before con-
structing the vignettes, unrealistic combinations have to
be eliminated [33]. Thus, we had to exclude the combina-
tion of "prevention" and "direct negative consequences"
as there are no prevention procedures with direct negative
effects in case of omission. In addition, we had to exclude
vignettes containing the combination of "one therapeutic
option" with either "treatments are partly well tolerated,
may partly have severe adverse effects"or "good evidenceBMC Health Services Research 2008, 8:260 http://www.biomedcentral.com/1472-6963/8/260
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for one/some treatment option/s, no evidence for other
treatment option/s". Table 2 shows a possible vignette of
our study.
By considering vignettes in such an abstract manner, we
wondered whether all patients could imagine such situa-
tions without further details. Therefore we considered
constructing vignettes with specific diseases and therapeu-
tic options. To avoid confusion with too much detail we
decided to present a semi-concrete solution as shown in
table 3.
To find out whether the abstract (see table 2) or the semi-
concrete version (see table 3) will be better accepted, bet-
ter understood and easier to rate for physicians as well as
for patients, we will conduct a cognitive pretest based on
think aloud techniques and cognitive probes [34,35].
To rate preferences for participation in treatment deci-
sions, we will use a 5-point scale presented by Sutherland
et al. [36]. We adapted the wording so that it could be
used by the patients and physicians (see table 4).
Statistical considerations
There is no consensus on how many factors can be
included in a factorial survey [33]. Beck and Opp [33]
conclude that subjects don't have any difficulties with
vignettes up to 6 dimensions, whereas Taylor [23] points
out that more than twenty are possible. Nevertheless,
most of the studies on factorial surveys have not used
more than 8 factors [29,30,33]. Considering the capacity
of the human's working memory, having difficulties to
capture more than 6 to 9 information units at the same
time [37], it makes sense to limit the number of factors
included in the vignettes. Therefore, in our main study we
will include only the 7 factors mentioned above.
Each participant will receive 11 vignettes for rating. Gen-
erally speaking, the number of vignettes for each partici-
pant depends on the time available, on the difficulty and
complexity of the vignettes and on statistical considera-
tions [33]. Previous studies used various numbers of
vignettes given to each subject, ranging from only 3 [30]
up to 40 [38] and even more in older investigations [39].
Beck and Opp [33] suggest that when there is no anteced-
ent survey of a specific issue and therefore no information
on how many vignettes could be tolerated, a number of
10 to 20 vignettes is reasonable. Furthermore, the number
of vignettes should be higher than the number of factors
and 10 vignettes seems to be the statistically best solution
(C. Sauer, University of Duisburg-Essen, personal com-
munication). Under these considerations and due to the
Table 1: Factors and levels included in the study
Factors Levels
1 Reason for the consultation ￿ Prevention
￿ Mild disease
￿ Severe disease
2 Time of negative consequences ￿ Immediate negative
￿ Negative in the future
3 Time until treatment should be started ￿ Treatment should be started immediately
￿ For the beginning of treatment there is no time pressure
4 Number of therapeutic options ￿ One therapeutic option
￿ More than one therapeutic option
5 Adverse effects of the treatment ￿ Treatment(s) is (are) well tolerated
￿ Treatment(s) could have severe adverse effects
￿ Treatments are partly well tolerated, may partly have severe adverse effects
6 Scientific evidence for the effectiveness of the treatment ￿ Good evidence for effect
￿ No evidence for Effect
￿ Good evidence for one/some treatment option/s, no evidence for other treatment 
option/s
7 Wish of the patient to participate ￿ The patient wishes to participate
￿ The patient does not wish to participate
Table 2: Example of a survey vignette
A patient consults his/her physician because of a mild disease that 
doesn't affect him right now but could lead to negative consequences 
in the future. There is no time pressure for beginning the treatment. 
There are various therapeutic options. Treatments are partly well 
tolerated and may partly have severe adverse effects. There is good 
evidence for all therapies. The patient in general wishes to participate 
in medical decisions.
Table 3: Example of a semi-concrete vignette
A patient consults his doctor because of mild elevated blood pressure 
that doesn't affect him right now but could lead to negative 
consequences in the future. There is no time pressure for beginning 
the treatment. The available therapeutic options are: a pill that could 
have adverse effects or a change of lifestyle that is well tolerated. 
There is good evidence for all therapeutic options. The patient in 
general wishes to participate in medical decisions.BMC Health Services Research 2008, 8:260 http://www.biomedcentral.com/1472-6963/8/260
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complexity of our seven-factor survey, 11 vignettes per
participant seem a reasonable choice to us. However, the
ideal number of vignettes given to each subject is an addi-
tional aspect that will be tested in the pretest.
The vignettes that will be included in the study will be ran-
domly chosen from all possible vignettes. For vignettes
selection, two statistical methods are mentioned in the lit-
erature [40]. "Random designs" randomly select the
desired number of vignettes from all possible vignettes.
The disadvantage of this method is that main and interac-
tion effects are confounded in the statistical analysis [22].
In "quota design" a planned selection of the vignettes is
suggested to reduce this source of error. Unfortunately,
quota designs in complex survey studies including many
factors and different numbers of factor levels are compu-
tationally demanding and reliable statistical solutions are
not available. Furthermore, quota designs are not applica-
ble, if factor combinations have to be excluded from the
study for logical reasons like in our design [40]. We there-
fore chose the random selection method.
Supported by a computer program 40 sets of vignettes will
be randomly drawn with replacement from the pool of
possible vignettes. The number of 40 results form a calcu-
lation based on the total number of vignettes, the
expected sample size and the number of vignettes that will
be given to each participant [33]. All 40 sets will be avail-
able for all three study groups (see "Participants"). Distri-
bution will be at random within groups.
Participants
To our knowledge there are no well established power
analysis methods for hierarchical models in factorial sur-
vey study designs. Thus, we decided to use conservative
ANOVA for fixed effects, special, main effects and interac-
tions [41]. The sample size was calculated assuming an
effect size of 0.25. Defining the single vignette as the unit
of analysis, we estimated that a minimum number of 438
observations would be required to detect an effect of 0.25
with a power of 1-β = 0.95. Since one subject has to rate
11 vignettes, 40 subjects would be necessary. As we don't
have estimations for intracluster correlation coefficient
(ICC) and in order to compensate for drop outs and miss-
ing data, we aim at a sample size of 100 persons.
This results in a total number of 300 participants who will
be included in the study: 100 general practitioners (GPs),
100 patients and 100 members of self-help groups.
We decided to include GPs because in Germany the gen-
eral practitioner is the first person in contact with the
patient. He is the one who guides the patient through the
health care system. Usually, medical treatment is coordi-
nated in a GP's surgery. As a consequence of the special
relationship between GP and patient, most important
decisions in the medical encounter are made in this con-
text. For the study we will recruit members of our regional
GP network as well as attendees of national conferences.
We plan to distinguish between the "usual" patient seen
in general practice and members of self-help groups
because we expect the latter to be more active in the deci-
sion making process. Patients will be recruited in surger-
ies. Members of self-help groups will also be contacted
resorting to self-help group nets.
Patients are included, if they are 18 years and older, able
to read German and able to give informed consent. We try
to cover different educational levels and age groups, bal-
anced for gender. Patients requiring emergency care are
excluded.
Material given to the participants
Before receiving the vignettes, all participants will be given
written information about the study and will have to sign
an informed consent form, approved by the local research
ethics committee, University of Marburg. Participants will
then fill in the survey questionnaire. After asking for
socio-demographic data and giving instructions 11
vignettes will be presented with the response format
described above. If the participants have any questions a
member of the research team will be present.
Data analysis
For our analysis we will use mixed models to estimate the
effects of factors and interactions. Factors will be coded as
dummy variables. In addition, we will examine differ-
ences between the three groups (physicians, practice
patients and members of self help groups). Furthermore,
Table 4: The 5-point scale for rating preference for participation in treatment decision making (adapted form Sutherland et al.)
Please check the statement that best describes what you belief would be ideal:
￿ The doctor should make the decision using all that is known about the treatment
￿ The doctor should make the decision but strongly consider the patients opinion
￿ The doctor and the patient should make the decision together on an equal basis
￿ The patient should make the decision but strongly consider the doctor's opinion
￿ The patient should make the decision using all he knows or learns about the treatmentBMC Health Services Research 2008, 8:260 http://www.biomedcentral.com/1472-6963/8/260
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we will investigate the influence of participants' demo-
graphic characteristics.
Linear models based on Ordinary Least Squares (OLS)
techniques, e.g. analysis of variance or multiple regres-
sion, cannot be used for analysis since they would assume
independence of all judgements [21]. However, responses
in factorial surveys are clustered in subjects [42]. There-
fore, hierarchical models based on maximum likelihood
estimators seem to be more appropriate for this design.
Hox et al. [42] demonstrated that choice between OLS-
estimation and hierarchical/mixed models is critical since
there are large calculational differences between the two
solutions.
Discussion
The findings of this factorial survey study will reflect nor-
mative values related to medical decision making. They
will reveal the effect of situational variations on consulta-
tion style preferences.
The results might help physicians to adapt their consulta-
tion style not only to individual patients but also to indi-
vidual treatment situations. Future implementation of
SDM and decision aids might be more successful than in
the past when communication patterns are tailored to
specific situations.
Furthermore, we hope to encourage researchers of the
effects of SDM to incorporate situational factors into their
study designs.
We believe that the factorial survey will become a much
more frequently used study design. A pure top-down
approach to meso- and macro-level-decisions in health
care is becoming less acceptable. In most instances many
stakeholders are involved ranging from patients to provid-
ers, payers and governments, to commercial manufactur-
ers of drugs and devices. Factorial survey designs can make
an invaluable contribution, since opinions, interests and
values of multiple stakeholders are systematically assessed
to inform policy decisions in health care.
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